Stage 2 Ovarian Cancer Treatment in Ahmedabad — Dr. Nishtha Tripathi Patel is an ESGO-certified gynaecological oncosurgeon offering specialist treatment for stage 2 ovarian cancer treatment at Sterling Hospitals, KD Hospital and Welcare Speciality Hospital in Ahmedabad.
On this page
- What this stage means
- Recommended treatment pathway
- Adjuvant therapy
- Outlook and survival data
- Booking
- FAQs
Stage 2 ovarian cancer treatment — What does this stage mean?
Stage 2 ovarian cancer has spread to pelvic structures (uterus, fallopian tubes, peritoneum). Treatment is cytoreductive surgery (removing all visible disease) followed by 6 cycles of platinum-based chemotherapy. Surgical completeness directly affects survival.
For broader information see our cancer overview and treatment page.
Recommended treatment pathway
Stage 2 ovarian cancer has spread to pelvic structures (uterus, fallopian tubes, peritoneum). Treatment is cytoreductive surgery (removing all visible disease) followed by 6 cycles of platinum-based chemotherapy. Surgical completeness directly affects survival.
Adjuvant therapy
Carboplatin-paclitaxel 6 cycles is standard. Bevacizumab may be added for poor-prognosis features. PARP inhibitor maintenance considered for BRCA-mutated or HRD-positive disease.
Outlook
5-year survival 50-70% depending on completeness of cytoreduction and response to chemotherapy.
External authoritative reference: NCCN Guidelines and ESGO Recommendations.
Booking
For an individualised treatment plan, share your reports on WhatsApp (+91 76988 00333) or book an appointment. Second opinions are available for patients already under care elsewhere.
FAQs
Where is stage 2 ovarian cancer treatment performed in Ahmedabad?
Dr. Nishtha Tripathi Patel treats this disease stage at Sterling Hospitals (Sindhubhavan), KD Hospital, and Welcare Speciality Hospital in Ahmedabad. The hospital is chosen based on the specific procedure needed and patient preference.
What is the typical hospital stay?
For minimally invasive surgery (robotic or laparoscopic), hospital stay is typically 3-4 days. For cytoreductive surgery or HIPEC, stay extends to 7-10 days. Chemoradiation is outpatient over 5-7 weeks.
What is the likely outcome?
5-year survival 50-70% depending on completeness of cytoreduction and response to chemotherapy. Outcomes are stage-dependent and individual; the figures above are averages from published series.
Is fertility preservation possible?
Fertility preservation is not standard for this stage. Egg or embryo cryopreservation may be considered before chemotherapy if applicable.
Can I get a second opinion before deciding?
Yes. Share your reports on WhatsApp (+91 76988 00333). Dr. Nishtha provides independent review of stage, pathology, imaging and proposed treatment within 24-48 hours.
Reviewed by Dr. Nishtha Tripathi Patel, MBBS, DGO, DNB, Fellowship Gynaecological Oncology, ESGO-certified.